`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`____________________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`____________________________
`
`MYLAN PHARMACEUTICALS INC.
`
`and
`
`DR. REDDY’S LABORATORIES, INC.,
`
`Petitioner
`
`v.
`
`HORIZON PHARMA USA, INC. and NUVO PHARMACEUTICALS
`(IRELAND) DESIGNATED ACTIVITY COMPANY.
`Patent Owners
`____________________________
`
`Case No. IPR2017-019951
`U.S. Patent No. 9,220,698
`____________________________
`
`PROPOSED SCHEDULING ORDER
`
`
`1 Petitioner Dr. Reddy’s Laboratories, Inc., from IPR2018-00894, has been joined
`as a Petitioner to this proceeding
`
`
`
`
`Pursuant to the Board’s Order dated January 25, 2019 (IPR2017-01995,
`
`Paper No. 60), the parties have meet and conferred and Petitioners hereby submit
`
`on behalf of Petitioners and Patent Owners an agreed schedule for IPR2017-01995,
`
`IPR2018-00272 and IPR2018-01341 consistent with the Board’s guidance
`
`contained in that Order.2
`
`
`
`IPR2017-01995
`(‘698 Patent)
`February 8, 2019
`(5:00pm ET)
`
`IPR2018-00272
`(‘208 Patent)
`N/A
`
`IPR2018-01341
`(‘208 Patent)
`N/A
`
`February 8, 2019 (5:00pm ET)
`
`February 22, 2019 (5:00pm ET)
`
`Already filed
`
`Already filed
`
`January 31, 2019
`
`Briefs Addressing
`Click to Call
`Patent Owner Brief
`Addressing Motion
`to Terminate
`Petitioner
`Responsive Brief
`Addressing Motion
`to Terminate
`Patent Owner
`Preliminary
`Response
`Due Date 1
`Patent Owner
`Response to
`Petition
`Due Date 2
`Petitioner Reply
`to Patent Owner
`Response
`Due Date 3
`Due Date 4
`Motions for
`Observation
`Motions to
`
`2 The same proposed scheduling order is being filed in IPR2018-00272.
`
`Already filed
`
`March 1, 2019
`
`April 26, 2019
`
`April 26, 2019
`
`N/A
`
`N/A
`
`May 17, 2019
`
`Same dates as
`IPR2018-00272 if
`joined and
`instituted.
`
`- 1 -
`
`
`
`
`
`Exclude
`Request for
`Oral Argument
`Due Date 5
`Response to
`Observation
`Opposition to
`Motion to
`Exclude
`Due Date 6
`Reply to Motion
`to Exclude
`Due Date 7
`Oral Argument
`
`
`
`Dated: January 31, 2019
`
`IPR2017-01995
`(‘698 Patent)
`
`IPR2018-00272
`(‘208 Patent)
`
`IPR2018-01341
`(‘208 Patent)
`
`May 24, 2019
`
`May 31, 2019
`
`June 14, 2019
`
`
`
`
`
`
`
`/Brandon M. White/
`Brandon M. White
`Reg. No. 52,354
`
`PERKINS COIE LLP
`700 13th Street, NW, Suite 600
`Washington, D.C. 20005
`Telephone: (202) 654-6204
`Facsimile: (202) 654-6211
`Email: bmwhite@perkinscoie.com
`
`Attorney for Mylan Pharmaceuticals Inc.
`
`
`
`- 2 -
`
`
`
`CERTIFICATE OF SERVICE
`The undersigned hereby certifies that the foregoing Proposed Scheduling
`
`
`
`Order was served electronically via email as follows:
`
`
`Patent Owners:
`
`Thomas A. Blinka
`Jonathan G. Graves
`Susan Krumplitsch
`Ellen Scordino
`Lauren Krickl
`Cooley LLP
`zIPR2017-01995@cooley.com
`
`Margaret J. Sampson
`Stephen M. Hash
`Jeffrey S. Gritton
`Baker Botts LLP
`pozen-
`vimovoBB@bakerbotts.com
`
`Dated: January 31, 2019
`
`Petitioner Dr. Reddy’s:
`
`Alan H. Pollack
`Dmitry V. Shelhoff
`Stuart D. Sender
`Louis H. Weinstein
`apollack@buddlarner.com
`dshelhoff@buddlarner.com
`ssender@buddlarner.com
`lweinstein@buddlarner.com
`
`
`
`
`
`
`
`
`/Brandon M. White/
`Brandon M. White
`
`Attorney for Mylan Pharmaceuticals Inc.
`
`
`
`
`
`